These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37348646)

  • 1. SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS.
    Lone MA; Zeng S; Bourquin F; Wang M; Huang S; Lin Z; Tang B; Zhang R; Hornemann T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159359. PubMed ID: 37348646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
    Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo c.113 T > C: p.L38R mutation of
    Liu X; He J; Yu W; Fan D
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):634-637. PubMed ID: 36204986
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent de novo
    Syeda SB; Lone MA; Mohassel P; Donkervoort S; Munot P; França MC; Galarza-Brito JE; Eckenweiler M; Asamoah A; Gable K; Majumdar A; Schumann A; Gupta SD; Lakhotia A; Shieh PB; Foley AR; Jackson KE; Chao KR; Winder TL; Catapano F; Feng L; Kirschner J; Muntoni F; Dunn TM; Hornemann T; Bönnemann CG
    J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):103-113. PubMed ID: 38041679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.
    Mohassel P; Donkervoort S; Lone MA; Nalls M; Gable K; Gupta SD; Foley AR; Hu Y; Saute JAM; Moreira AL; Kok F; Introna A; Logroscino G; Grunseich C; Nickolls AR; Pourshafie N; Neuhaus SB; Saade D; Gangfuß A; Kölbel H; Piccus Z; Le Pichon CE; Fiorillo C; Ly CV; Töpf A; Brady L; Specht S; Zidell A; Pedro H; Mittelmann E; Thomas FP; Chao KR; Konersman CG; Cho MT; Brandt T; Straub V; Connolly AM; Schara U; Roos A; Tarnopolsky M; Höke A; Brown RH; Lee CH; Hornemann T; Dunn TM; Bönnemann CG
    Nat Med; 2021 Jul; 27(7):1197-1204. PubMed ID: 34059824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent
    Dohrn MF; Beijer D; Lone MA; Bayraktar E; Oflazer P; Orbach R; Donkervoort S; Foley AR; Rose A; Lyons M; Louie RJ; Gable K; Dunn T; Chen S; Danzi MC; Synofzik M; Bönnemann CG; Nazlı Başak A; Hornemann T; Zuchner S
    J Neurol Neurosurg Psychiatry; 2024 Feb; 95(3):201-205. PubMed ID: 38041684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
    Rotthier A; Penno A; Rautenstrauss B; Auer-Grumbach M; Stettner GM; Asselbergh B; Van Hoof K; Sticht H; Lévy N; Timmerman V; Hornemann T; Janssens K
    Hum Mutat; 2011 Jun; 32(6):E2211-25. PubMed ID: 21618344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.
    Johnson JO; Chia R; Miller DE; Li R; Kumaran R; Abramzon Y; Alahmady N; Renton AE; Topp SD; Gibbs JR; Cookson MR; Sabir MS; Dalgard CL; Troakes C; Jones AR; Shatunov A; Iacoangeli A; Al Khleifat A; Ticozzi N; Silani V; Gellera C; Blair IP; Dobson-Stone C; Kwok JB; Bonkowski ES; Palvadeau R; Tienari PJ; Morrison KE; Shaw PJ; Al-Chalabi A; Brown RH; Calvo A; Mora G; Al-Saif H; Gotkine M; Leigh F; Chang IJ; Perlman SJ; Glass I; Scott AI; Shaw CE; Basak AN; Landers JE; Chiò A; Crawford TO; Smith BN; Traynor BJ; ; Smith BN; Ticozzi N; Fallini C; Gkazi AS; Topp SD; Scotter EL; Kenna KP; Keagle P; Tiloca C; Vance C; Troakes C; Colombrita C; King A; Pensato V; Castellotti B; Baas F; Ten Asbroek ALMA; McKenna-Yasek D; McLaughlin RL; Polak M; Asress S; Esteban-Pérez J; Stevic Z; D'Alfonso S; Mazzini L; Comi GP; Del Bo R; Ceroni M; Gagliardi S; Querin G; Bertolin C; van Rheenen W; Rademakers R; van Blitterswijk M; Lauria G; Duga S; Corti S; Cereda C; Corrado L; Sorarù G; Williams KL; Nicholson GA; Blair IP; Leblond-Manry C; Rouleau GA; Hardiman O; Morrison KE; Veldink JH; van den Berg LH; Al-Chalabi A; Pall H; Shaw PJ; Turner MR; Talbot K; Taroni F; García-Redondo A; Wu Z; Glass JD; Gellera C; Ratti A; Brown RH; Silani V; Shaw CE; Landers JE; Dalgard CL; Adeleye A; Soltis AR; Alba C; Viollet C; Bacikova D; Hupalo DN; Sukumar G; Pollard HB; Wilkerson MD; Martinez EM; Abramzon Y; Ahmed S; Arepalli S; Baloh RH; Bowser R; Brady CB; Brice A; Broach J; Campbell RH; Camu W; Chia R; Cooper-Knock J; Ding J; Drepper C; Drory VE; Dunckley TL; Eicher JD; England BK; Faghri F; Feldman E; Floeter MK; Fratta P; Geiger JT; Gerhard G; Gibbs JR; Gibson SB; Glass JD; Hardy J; Harms MB; Heiman-Patterson TD; Hernandez DG; Jansson L; Kirby J; Kowall NW; Laaksovirta H; Landeck N; Landi F; Le Ber I; Lumbroso S; MacGowan DJL; Maragakis NJ; Mora G; Mouzat K; Murphy NA; Myllykangas L; Nalls MA; Orrell RW; Ostrow LW; Pamphlett R; Pickering-Brown S; Pioro EP; Pletnikova O; Pliner HA; Pulst SM; Ravits JM; Renton AE; Rivera A; Robberecht W; Rogaeva E; Rollinson S; Rothstein JD; Scholz SW; Sendtner M; Shaw PJ; Sidle KC; Simmons Z; Singleton AB; Smith N; Stone DJ; Tienari PJ; Troncoso JC; Valori M; Van Damme P; Van Deerlin VM; Van Den Bosch L; Zinman L; Landers JE; Chiò A; Traynor BJ; Angelocola SM; Ausiello FP; Barberis M; Bartolomei I; Battistini S; Bersano E; Bisogni G; Borghero G; Brunetti M; Cabona C; Calvo A; Canale F; Canosa A; Cantisani TA; Capasso M; Caponnetto C; Cardinali P; Carrera P; Casale F; Chiò A; Colletti T; Conforti FL; Conte A; Conti E; Corbo M; Cuccu S; Dalla Bella E; D'Errico E; DeMarco G; Dubbioso R; Ferrarese C; Ferraro PM; Filippi M; Fini N; Floris G; Fuda G; Gallone S; Gianferrari G; Giannini F; Grassano M; Greco L; Iazzolino B; Introna A; La Bella V; Lattante S; Lauria G; Liguori R; Logroscino G; Logullo FO; Lunetta C; Mandich P; Mandrioli J; Manera U; Manganelli F; Marangi G; Marinou K; Marrosu MG; Martinelli I; Messina S; Moglia C; Mora G; Mosca L; Murru MR; Origone P; Passaniti C; Petrelli C; Petrucci A; Pozzi S; Pugliatti M; Quattrini A; Ricci C; Riolo G; Riva N; Russo M; Sabatelli M; Salamone P; Salivetto M; Salvi F; Santarelli M; Sbaiz L; Sideri R; Simone I; Simonini C; Spataro R; Tanel R; Tedeschi G; Ticca A; Torriello A; Tranquilli S; Tremolizzo L; Trojsi F; Vasta R; Vacchiano V; Vita G; Volanti P; Zollino M; Zucchi E
    JAMA Neurol; 2021 Oct; 78(10):1236-1248. PubMed ID: 34459874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.
    Kölbel H; Kraft F; Hentschel A; Czech A; Gangfuss A; Mohassel P; Nguyen C; Stenzel W; Schara-Schmidt U; Preuße C; Roos A
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627278
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis.
    Li C; Hou Y; Wei Q; Lin J; Jiang Z; Jiang Q; Yang T; Xiao Y; Huang J; Cheng Y; Ou R; Liu K; Chen X; Song W; Zhao B; Wu Y; Cao B; Chen Y; Shang H
    Hum Genomics; 2023 Mar; 17(1):28. PubMed ID: 36966328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations.
    Wang P; Wei Q; Li H; Wu ZY
    Chin Med J (Engl); 2023 Jan; 136(2):176-183. PubMed ID: 36801857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment.
    Fiorillo C; Capodivento G; Geroldi A; Tozza S; Moroni I; Mohassel P; Cataldi M; Campana C; Morando S; Panicucci C; Pedemonte M; Brolatti N; Siliquini S; Traverso M; Baratto S; Debellis D; Magri S; Prada V; Bellone E; Salpietro V; Donkervoort S; Gable K; Gupta SD; Dunn TM; Bönnemann CG; Taroni F; Bruno C; Schenone A; Mandich P; Nobbio L; Nolano M
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12842. PubMed ID: 35904184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases.
    Lone MA; Bourquin F; Hornemann T
    Adv Exp Med Biol; 2022; 1372():47-56. PubMed ID: 35503173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
    Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
    J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
    Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
    Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.
    Tamehiro N; Mujawar Z; Zhou S; Zhuang DZ; Hornemann T; von Eckardstein A; Fitzgerald ML
    J Biol Chem; 2009 Sep; 284(37):24881-90. PubMed ID: 19592499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis.
    Kuo A; Checa A; Niaudet C; Jung B; Fu Z; Wheelock CE; Singh SA; Aikawa M; Smith LE; Proia RL; Hla T
    Elife; 2022 Oct; 11():. PubMed ID: 36197001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of SPTLC1-related disorders: a novel case of 'Ser331 syndrome' that expand the phenotype of hereditary sensory and autonomic neuropathy type 1A and motor neuron diseases.
    Lorenzoni PJ; Bayer DL; Ducci RD; Fustes OJH; do Vale Pascoal Rodrigues PR; Werneck LC; Kay CSK; Scola RH
    Neurol Sci; 2023 Jul; 44(7):2551-2554. PubMed ID: 36964315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.